OBJECTIVE: Common estimates of the prevalence rate for pial arteriovenous malformations
(AVMs) of the brain vary widely, and their accuracy is questionable. Our objective was to …

Although liquid adhesives or glue have been used as embolic agents for nearly three
decades, experience with them outside of neurointerventional indications is generally …

Intracranial arteriovenous malformations (AVMs) are relatively uncommon but increasingly
recognized lesions that can cause serious neurological symptoms or death. Although AVMs …

BACKGROUND AND PURPOSE: We report our experiences in the treatment of intracranial
arteriovenous malformations (AVMs) with Onyx embolization before neuro-or radiosurgery …

Introduction Onyx has emerged in the recent years as a new embolic material. We present
our experience with Onyx in the curative embolization of brain cerebral arteriovenous …

Brain AVMs are angioarchitecturally and hemodynamically complex systems of
arteriovenous shunts with specific neurovascular relationships, a variable and unpredictable …

Modern imaging techniques are increasingly discovering arteriovenous malformations of the
brain, many of which are still unruptured. Advances in microsurgery, endovascular …

OBJECTIVE: To report our experience with the treatment of brain arteriovenous
malformations (AVM) with microsurgical resection after embolization with Onyx liquid …

OBJECTIVE: Embolization is an important therapeutic modality in the multidisciplinary
management of arteriovenous malformations (AVM); however, prior series have reported a …

PURPOSE: To report the initial clinical experience with the use of n-butyl cyanoacrylate
(NBCA) for embolization of acute arterial hemorrhage from varied etiologies and at varied …